Drug Shortage Report for TYLENOL WITH CODEINE NO. 2 - TAB
| Report ID | 279025 |
| Drug Identification Number | 02163934 |
| Brand name | TYLENOL WITH CODEINE NO. 2 - TAB |
| Common or Proper name | english |
| Company Name | JANSSEN INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | ACETAMINOPHEN CAFFEINE CODEINE PHOSPHATE |
| Strength(s) | 300MG 15MG 15MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | english |
| Anatomical Therapeutical Chemical (ATC) code | N02AJ |
| Anatomical Therapeutical Chemical (ATC) description | OPIOIDS |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | 2021-02-02 |
| Actual start date | |
| Estimated end date | 2026-03-02 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2026-03-07 |
| Company comments | english |
| Health Canada comments | english |
| Tier 3 Status | No |
| Contact Address | 19 GREEN BELT DRIVE TORONTO, ONTARIO CANADA M3C 1L9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2026-03-07 | French | Compare |
| v1 | 2026-03-07 | English | Compare |
Showing 1 to 2 of 2